BioSpecifics Technologies Corp (BSTC) financial statements (2022 and earlier)

Company profile

Business Address 35 WILBUR ST
LYNBROOK, NY 11563
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments89,23980,88459,30849,01833,48520,71112,592
Cash and cash equivalents4,99913,1767,3344,7635,1389,8115,625
Short-term investments84,24067,70751,97444,25528,34810,9006,967
Receivables19,06616,5194,6554,3063,4653,6405,004
Capitalized contract cost 185
Deferred costs  1,7941,4521,018570 
Prepaid expense and other current assets327
Income taxes receivable256
Other undisclosed current assets96664762462440122895
Total current assets:109,27198,23466,38155,40038,36925,14918,273
Noncurrent Assets
Operating lease, right-of-use asset239
Long-term investments and receivables16,5691,1005,7463,7713,5971,250 
Long-term investments16,5691,1005,7463,7713,5971,250 
Intangible assets, net (including goodwill)573444398258275295216
Intangible assets, net (excluding goodwill)573444398258275295216
Deferred costs  7321,9762,8513,2713,350
Other undisclosed noncurrent assets 3141,7403,2906061,0621,413
Total noncurrent assets:17,3821,8588,6169,2967,3295,8784,979
TOTAL ASSETS:126,653100,09274,99664,69645,69831,02723,252
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9981,799934739611544634
Accrued liabilities3641,503151517465 
Employee-related liabilities209173215183165169163
Taxes payable355 69    
Other undisclosed accounts payable and accrued liabilities70122499505372309471
Debt69      
Deferred revenue and credits1,0581,1801494969
Other undisclosed current liabilities35570514778787878
Total current liabilities:1,4222,5042,1391,997839671782
Noncurrent Liabilities
Long-term debt and lease obligation167      
Operating lease, liability167
Liabilities, other than long-term debt573 5,3416,4184999138
Deferred revenue and credits5,3416,4184999138
Deferred income tax liabilities573
Total noncurrent liabilities:740 5,3416,4184999138
Total liabilities:2,1622,5047,4808,414888770920
Stockholders' equity
Stockholders' equity attributable to parent124,49197,58967,51756,28244,81030,25722,332
Common stock8888777
Treasury stock, value(11,519)(10,898)(7,898)(7,282)(6,233)(4,431)(3,601)
Additional paid in capital39,35636,30233,46832,94531,79725,05920,952
Retained earnings96,64772,17741,93930,61119,2399,6214,975
Total stockholders' equity:124,49197,58967,51756,28244,81030,25722,332
TOTAL LIABILITIES AND EQUITY:126,653100,09274,99664,69645,69831,02723,252

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues38,18832,96127,44426,25122,75014,07714,467
Revenue, net27,44426,25122,75014,07714,467
Gross profit:38,18832,96127,44426,25122,75014,07714,467
Operating expenses(9,876)(9,563)(9,766)(9,225)(8,307)(7,877)(6,587)
Other undisclosed operating income     79964
Operating income:28,31223,39917,67817,02614,4436,9997,944
Nonoperating income1,9871,3996883491083326
Investment income, nonoperating1,9871,295637296933226
Other nonoperating income (expense)(0)1045153151 
Income from continuing operations before income taxes:30,29924,79718,36617,37514,5517,0337,971
Income tax expense(5,829)(4,744)(7,038)(6,003)(4,933)(2,387)(2,685)
Net income available to common stockholders, diluted:24,47020,05311,32811,3729,6184,6465,286

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:24,47020,05311,32811,3729,6184,6465,286
Comprehensive income, net of tax, attributable to parent:24,47020,05311,32811,3729,6184,6465,286

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: